Summit Therapeutics, Inc. (SMMT)
17.33
+0.33
(+1.94%)
USD |
NASDAQ |
May 27, 16:00
17.33
0.00 (0.00%)
After-Hours: 17:31
Summit Therapeutics Free Cash Flow : -387.48M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Revolution Medicines, Inc. | -1.072B |
| BioMarin Pharmaceutical, Inc. | 759.12M |
| Merck & Co., Inc. | 14.12B |
| Denali Therapeutics, Inc. | -419.23M |
| Relay Therapeutics, Inc. | -213.38M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -122.29M |
| Cash from Investing (Quarterly) | -0.238M |
| Cash from Financing (Quarterly) | 3.797M |
| Free Cash Flow Per Share (Quarterly) | -0.158 |
| Free Cash Flow to Equity (Quarterly) | -121.68M |
| Free Cash Flow to Firm (Quarterly) | -122.54M |
| Free Cash Flow Yield | -2.95% |